Mingjiao Sun, Yi Zhou, Xuefang Zhuo, Sheng Wang, Shisheng Jiang, Zhihuan Peng, Ke Kang, Xuehua Zheng,* and Mingna Sun*. Design, Synthesis and Cytotoxicity Evaluation of Novel IndoleDerivatives Containing Benzoic Acid Group as Potential AKR1C3 Inhibitors, Chem. Biodiversity, 2020, 17, e2000519
Zan Jiang, Xuehua Zheng*, Zhong Li, Shuqiong Pan, Xiaoyu Wang, Chen Zhang, Zhe Li, Hai Bin Luo, Deyan Wu*, Xiong Cai*. 3D-QSAR modeling of Phosphodiesterase-5 inhibitors: evaluation and comparison of the receptor- and ligand-based alignments, Medicinal Chemistry Research, 2019, 28(6): 820-830.
Xuehua Zheng, Zan Jiang, Xiaolin Li, Chen Zhang, Zhe Li, Yinuo Wu, Xinhua Wang, Chao Zhang, Hai-bin Luo, Jun Xu*, Deyan Wu*. Screening, synthesis, crystal structure, and molecular basis of 6-amino-4-phenyl-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitriles as novel AKR1C3 inhibitors. Bioorganic & Medicinal Chemistry, 2018,26(22), 5934-5943.
Xuehua Zheng, Xu-Nian Wu, Jin-Yi Chen, Hai-Bin Luo, Deyan Wu*, Yinuo Wu*. Transitional Metal-free catalyzed C-H arylation of unactivated arenes with 8-hydroxyquinoline as a promoter. Synthesis. 2018, 50, 1721–1727.
Yiyou Huang, Xin Liu, Deyan Wu, Guihua Tang, Zengwei Lai, Xuehua Zheng*, Sheng, Yin*, Hai-bin Luo*. The discovery, complex crystal structure, and recognition mechanism of a novel natural PDE4 inhibitor from Selaginella pulvinata. Biochem Pharmacol, 2017,130, 51-59.
Xuehua Zheng, Siyuan Zhou, Chen Zhang, Deyan Wu, Hai-bin Luo, Yinuo Wu*. Docking-assisted 3D-QSAR studies on xanthones as α-glucosidase inhibitors. J Mol Model, 2017,23(9), 272.
Xuehua Zheng, Yinuo Wu, Deyan Wu, Xinhua Wang, Chao Zhang, Xiaolei Guo, Hai-bin Luo*. 3D-QSAR studies of 3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)- benzoic acids as AKR1C3 inhibitors: Highlight the importance of molecular docking in conformation generation, Bioorg Med Chem Lett, 2016,26(23), 5631-5638.
Cuiyun Li, Yining Zhao, Xuehua Zheng, Hong Zhang, Liping Zhang, Yunyun Chen, Qing Li*, Xiaopeng Hu*, In vitro CAPE inhibitory activity towards human AKR1C3 and the molecular basis. Chemico-Biological Interactions, 2016, 253: 60-65.
Yining Zhao, Xuehua Zheng, Hong Zhang, Jing Zhai, Liping Zhang, Cuiyun Li, Kaixin Zeng, Yunyun Chen, Qing Li*, Xiaopeng Hu*. In vitro inhibition of AKR1Cs by sulphonylureas and the structural basis, Chem Biol Interact, 2015, 240, 310-315.
郑雪花,赵奕宁,王小雨,潘淑琼,张超. AKR1C3酶抑制剂筛选模型的建立及在中药五环三萜类活性成分筛选中的应用. 中药材,2018(08):1851-1856
郑雪花,吴波,郑国栋,张建业,遆慧慧,喻丽红,季红,张超. 丰富感性认识,提高西医院校药用植物学教学质量. 广东化工,2018,45(07):260+245.
郑雪花,姜赞,王小雨,潘淑琼,蔡雄,李钟,刘塔斯. 黄酮类化合物对AKR1C3抑制作用的研究. 今日药学,2018,28(08):505-509.
Xuehua Zheng, Liping Zhang, Weijia Chen, Yunyun Chen, Wei Xie, Xiaopeng Hu*, Partial inhibition of aldose reductase by nitazoxanide and its molecular basis, ChemMedChem, 2012, 7(11): 1921-1923
Xuehua Zheng, Liping Zhang, Jing Zhai, Yunyun Chen, Haibin Luo*, Xiaopeng Hu*, The molecular basis for inhibition of sulindac and its metabolites towards human aldose reductase, FEBS Letters, 2012, 586(1): 55-59
Liping Zhang, Hong Zhang, Yining Zhao, Zhe Li, Shangke Chen, Jing Zhai, Yunyun Chen, Wei Xie, Zhong Wang, Qing Li, Xuehua Zheng*, Xiaopeng Hu*, Inhibitor selectivity between aldo-keto reductase superfamily members AKR1B10 and AKR1B1: role of Trp112 (Trp111), FEBS Letters, 2013, 587(22): 3681-3686
Xuehua Zheng, Yong-Xian Shao, Zhe Li, Ming Liu, Xianzhang Bu, Hai-Bin Luo*, Xiaopeng Hu*, Quantitative structure-retention relationship of curcumin and its analogues, J Sep Sci,2012, 35(4):505-512
郑雪花, 吴德燕, 姜赞, 王小雨, 潘淑琼. 一种二氢吡喃并吡唑类化合物及其制备方法和应用, 2018-09-27, 中国, CN201811133143.4.
吴文浩, 郑雪花, 张超, 陈连娣. 一种呫吨酮类化合物及其制备方法和应用, 2018-11-15, 中国, CN201811356868.X.
